Ernexa Therapeutics (ERNA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to -$1.2 million.
- Ernexa Therapeutics' Other Gross PP&E Adjustments fell 2081.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 2081.27%. This contributed to the annual value of -$859000.0 for FY2024, which is 9749.67% up from last year.
- Ernexa Therapeutics' Other Gross PP&E Adjustments amounted to -$1.2 million in Q3 2025, which was down 2081.27% from -$943000.0 recorded in Q2 2025.
- Over the past 5 years, Ernexa Therapeutics' Other Gross PP&E Adjustments peaked at -$859000.0 during Q4 2024, and registered a low of -$36.7 million during Q1 2024.
- For the 5-year period, Ernexa Therapeutics' Other Gross PP&E Adjustments averaged around -$11.6 million, with its median value being -$1.9 million (2022).
- The largest annual percentage gain for Ernexa Therapeutics' Other Gross PP&E Adjustments in the last 5 years was 9749.67% (2024), contrasted with its biggest fall of 267927.38% (2024).
- Over the past 5 years, Ernexa Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$2.7 million in 2021, then fell by 10.1% to -$2.9 million in 2022, then tumbled by 1069.17% to -$34.3 million in 2023, then soared by 97.5% to -$859000.0 in 2024, then tumbled by 41.91% to -$1.2 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.2 million for Q3 2025, versus -$943000.0 for Q2 2025 and -$1.2 million for Q1 2025.